ConductScience.org, home

Paper33782830

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor.

Humeniuk R and 11 others. Clin Pharmacokinet, 2021. Cited by 104 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor. Papers, record 33782830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33782830

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
104
iCite
Relative citation ratio, by iCite
6.87
iCite
Revised in PubMed
2024-08-10
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Humeniuk RRitahttps://orcid.org/0000-0003-1573-793X
2Mathias AAnita
3Kirby BJBrian J
4Lutz JDJustin D
5Cao HHuyen
6Osinusi AAnu
7Babusis DDarius
8Porter DDanielle
9Wei XXuelian
10Ling JJohn
11Reddy YSY Sunila
12German PPolina

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenosine MonophosphateMajor topic
AlanineMajor topic
Antiviral AgentsMajor topic
COVID-19 Drug TreatmentMajor topic
Adenosine
Adult
Animals
Area Under Curve
Dose-Response Relationship, Drug
Drug Interactions
Furans
Half-Life
Humans
Metabolic Clearance Rate
Pyrroles
SARS-CoV-2
Triazines

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132145190Liver injury in COVID-19: management and challenges.Lancet Gastroenterol Hepatol2020https://conductscience.org/library/papers/32145190PubMed
232598831Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.N Engl J Med2020https://conductscience.org/library/papers/32598831PubMed
332340833Coronavirus disease 2019 (COVID-19): A literature review.J Infect Public Health2020https://conductscience.org/library/papers/32340833PubMed
432649078Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.N Engl J Med2020https://conductscience.org/library/papers/32649078PubMed
532574236Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?Front Pharmacol2020https://conductscience.org/library/papers/32574236PubMed
632054787Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/32054787PubMed
726934220Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.Nature2016https://conductscience.org/library/papers/26934220PubMed
832668216Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.Cell Rep2020https://conductscience.org/library/papers/32668216PubMed
933501997Physiologically-Based Pharmacokinetic Modeling of Remdesivir and Its Metabolites to Support Dose Selection for the Treatment of Pediatric Patients With COVID-19.Clin Pharmacol Ther2021https://conductscience.org/library/papers/33501997PubMed
1032884226Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.World J Gastroenterol2020https://conductscience.org/library/papers/32884226PubMed
1132284326Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.J Biol Chem2020https://conductscience.org/library/papers/32284326PubMed
1232516797Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.Nature2020https://conductscience.org/library/papers/32516797PubMed
1328659436Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.Sci Transl Med2017https://conductscience.org/library/papers/28659436PubMed
1432278175COVID-19: A promising cure for the global panic.Sci Total Environ2020https://conductscience.org/library/papers/32278175PubMed
1532119133Inclusion of Adolescents With Adults in Phase 3 Clinical Trials: Overview of the Current State and a Call for Action.J Clin Pharmacol2020https://conductscience.org/library/papers/32119133PubMed
1628262699GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses.Sci Rep2017https://conductscience.org/library/papers/28262699PubMed
1732459919Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.N Engl J Med2020https://conductscience.org/library/papers/32459919PubMed
1832553666COVID-19 and the liver.J Hepatol2020https://conductscience.org/library/papers/32553666PubMed
1932967965Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action.J Biol Chem2020https://conductscience.org/library/papers/32967965PubMed
2020724498Impact of ignoring extraction ratio when predicting drug-drug interactions, fraction metabolized, and intestinal first-pass contribution.Drug Metab Dispos2010https://conductscience.org/library/papers/20724498PubMed

See all 28 referencesDownload CSV of references

Cited by83

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.

PMIDTitleJournalYearIn PapersSource
42316440Thorough QT/QTc Clinical Study to Evaluate the Effect of Remdesivir on Cardiac Repolarization in Healthy Participants.Clin Transl Sci2026https://conductscience.org/library/papers/42316440PubMed
42104169Pharmacokinetics, Safety, and Tolerability of Obeldesivir in Healthy Japanese and White Participants.Eur J Drug Metab Pharmacokinet2026https://conductscience.org/library/papers/42104169PubMed
42041372Antibiotics and Other Drugs Removal by the CytoSorb® Haemoadsorber: A Systematic Review of Available Evidence.Antibiotics (Basel)2026https://conductscience.org/library/papers/42041372PubMed
41920295Prospective Study of Treatment with Ensitrelvir for COVID-19 in Patients Undergoing Hemodialysis (PROTECT-HD).Infect Dis Ther2026https://conductscience.org/library/papers/41920295PubMed
41769697Remdesivir in COVID-19: pros and cons.Front Pharmacol2026https://conductscience.org/library/papers/41769697PubMed
41719342Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential.PLoS One2026https://conductscience.org/library/papers/41719342PubMed
41516274Natural Fatty Acids as Dual ACE2-Inflammatory Modulators: Integrated Computational Framework for Pandemic Preparedness.Int J Mol Sci2025https://conductscience.org/library/papers/41516274PubMed
41458994Scoping review about pathogenesis, risk factors, and treatment of venous and arterial thrombosis in coronavirus infection.Front Cardiovasc Med2025https://conductscience.org/library/papers/41458994PubMed
41353130Baseline medication profile and risk of CYP3A4 mediated drug-drug interactions among COVID-19 hospitalized patients in Spain.BMC Infect Dis2025https://conductscience.org/library/papers/41353130PubMed
41239269Severe myocardium suppression in two congenital heart disease patients after remdesivir use - a case report.BMC Pediatr2025https://conductscience.org/library/papers/41239269PubMed
41222450Characterization of Drug-Drug Interactions for Remdesivir, an Intravenous Antiviral for SARS-CoV-2, in Healthy Participants.Clin Transl Sci2025https://conductscience.org/library/papers/41222450PubMed
41031289Phylogenetic meta-analysis of persistent SARS-CoV-2 infections in immunocompromised individuals highlights the challenges of robust evolutionary rate estimation caused by low genetic diversity.Virus Evol2025https://conductscience.org/library/papers/41031289PubMed
40700154A Novel HPLC-MS/MS Method for the Intracellular Quantification of the Active Triphosphate Metabolite of Remdesivir: GS-443902.J Xenobiot2025https://conductscience.org/library/papers/40700154PubMed
40573427Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?Viruses2025https://conductscience.org/library/papers/40573427PubMed
40514753Comparative transcriptome analysis of PBMCs in cats diagnosed with and recovered from FIPV.Lab Anim Res2025https://conductscience.org/library/papers/40514753PubMed
40261493Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19.Clin Pharmacokinet2025https://conductscience.org/library/papers/40261493PubMed
40196380Antivirals in COVID-19: A Focus on Pediatric Cardiac Patients.Can J Infect Dis Med Microbiol2025https://conductscience.org/library/papers/40196380PubMed
40146185Application of Machine Learning and Mechanistic Modeling to Predict Intravenous Pharmacokinetic Profiles in Humans.J Med Chem2025https://conductscience.org/library/papers/40146185PubMed
39945591Pharmacokinetics of SARS-CoV-2 RNA Polymerase Inhibitor Remdesivir in Participants With Moderate and Severe Hepatic Impairment.Clin Transl Sci2025https://conductscience.org/library/papers/39945591PubMed
39871315Remdesivir-induced severe hypoglycemia in an elderly man without diabetes: a case report.J Pharm Health Care Sci2025https://conductscience.org/library/papers/39871315PubMed

See all 83 cited byDownload CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33782830

GET https://conductscience.org/api/papers/v1/33782830/references?page=2